Priorities for Research on Meningococcal Disease and the Impact of Serogroup A Vaccination in the African Meningitis Belt
To review how the research agenda for meningococcal disease in Africa has been changed by the advent of a serogroup A polysaccharide/tetanus toxoid protein conjugate vaccine and to define a new set of research priorities for study of meningococcal infection in Africa, a meeting of 41 scientists was held in Dakar, Senegal on April 24 to 25, 2012. This paper, published in Vaccine, presents the research recommendations developed during the course of this meeting. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Greenwood B
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Greenwood B. Priorities for Research on Meningococcal Disease and the Impact of Serogroup A Vaccination in the African Meningitis Belt. Vaccine. 2013;31(11):1453-1457.